MiamiGent
2 years ago
SPRB
Closed today at $2.53 +$0.11 (+4.55%)
Volume 13,195,578
A day of consolidating. And prolly the company adding to the treasury. That's ok- a stronger company to complete trials and execute a rollout.
Any news; further licensing beyond Japan, insider buys, positive trial updates, etc. and this could rocket. Be in position. Allow good things to come to us, whenever they do.
https://stockcharts.com/h-sc/ui?s=SPRB
MG
MiamiGent
2 years ago
SPRB
Closed today at $2.53 +$0.11 (+4.55%)
Volume 13,195,578
A day of consolidating. And prolly the company adding to the treasury. That's ok- a stronger company to complete trials and execute a rollout.
Any news; further licensing beyond Japan, insider buys, positive trial updates, etc. and this could rocket. Be in position. Allow good things to come to us, whenever they do.
https://stockcharts.com/h-sc/ui?s=SPRB
MG
TheFinalCD
2 years ago
On January 9, 2023, the Company issued a press release providing a
corporate update that included updates on its clinical programs and
an estimate that its cash, cash equivalents and investments as of
December 31, 2022 were approximately $79 million. This amount is
unaudited and preliminary and is subject to completion of financial
closing procedures. Additional information and disclosure would be
required for a more complete understanding of the Company’s
financial position and results of operations as of December 31,
2022.
https://ih.advfn.com/stock-market/NASDAQ/spruce-biosciences-SPRB/stock-news/89937088/spruce-biosciences-provides-clinical-program-updat
pzottkpz
2 years ago
I found it !
I answered my $SPRB
question for my friend
(no help from the pumper, of course)
In February 2022, the SEC declared effective a registration statement on Form S-3 (Shelf Registration) covering the sale of up to $200.0 million of the Company's securities. Also, in February 2022, the Company entered into an Open Market Sales AgreementSM (Sales Agreement), with Jefferies LLC (Jefferies), pursuant to which the Company may elect to issue and sell, from time to time, shares of common stock having an aggregate offering price of up to $21.0 million under the Shelf Registration through Jefferies acting as the sales agent and/or principal. As of September 30, 2022, the Company has not issued any shares of common stock pursuant to the Sales Agreement.
wonder why …….
oh noooooooooooooooo